Insys Therapeutics Inc Chandler, AZ - 85224

Insys Therapeutics Inc is categorized under Biological Products Manufacturers in Chandler, AZ and active since 2012.

Insys Therapeutics Inc was established in 2012, and today employs 1 to 4, earning Unknown per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 3254120 by the NAICS.

If you are seeking more information, feel free to contact Michael Babich, Chief Executive Officer at the company’s headquarters by writing to 444 South Ellis St # 1, Chandler, Arizona AZ 85224 or by phoning (602) 910-2617. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Insys Therapeutics Inc
Contact Person: Michael Babich, Chief Executive Officer
Address: 444 South Ellis St # 1, Chandler, Arizona 85224
Phone Number: (602) 910-2617
Website Address: insysrx.com
Annual Revenue (USD): Unknown
Founded: 2012
Location Type: Headquarters
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biological Products Manufacturers
SIC Code: 2836
NAICS Code: 3254120
Share This Business:

Insys Therapeutics Inc was started in 2012 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Michael Babich, Chief Executive Officer for inquiries that concern Insys Therapeutics Inc by calling the company number (602) 910-2617, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Insys Therapeutics Inc can be found at the coordinates 33.29965,-111.88521 as well as the street address 444 South Ellis St # 1 in Chandler, Arizona 85224.

For its online presence, you may visit Insys Therapeutics Inc’s website at insysrx.com and engage with its social media outlets through on Twitter and on Facebook.